763
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Frequency and severity of enzootic pneumonia-like lesions in Greek swine herds and their association with different vaccination protocols against Mycoplasma hyopneumoniae

, , , ORCID Icon & ORCID Icon
Pages 540-547 | Received 23 Dec 2021, Accepted 02 Aug 2022, Published online: 11 Aug 2022

References

  • Aalund O, Willeberg P, Mandrup M, Riemann H. 1976. Lung lesions at slaughter: associations to factors in the pig herd. Nord Vet Med. 28:487–495.
  • Amanfu W, Weng CN, Ross RF, Barnes HJ. 1984. Diagnosis of mycoplasmal pneumonia of swine – sequential study by direct immunofluorescence. Am J Vet Res. 45:1349–1352.
  • Annual Porcine Census. 2021. [accessed 2021 Jun 4]. http://www.minagric.gr/index.php/el/eservisesmenu-2/e-services-minagric-anual-pig-census-gr.
  • Baccaro MR, Hirose F, Umehara O, Gonçalves LC, Doto DS, Paixão R, Shinya LT, Moreno AM. 2006. Comparative efficacy of two single-dose bacterins in the control of Mycoplasma hyopneumoniae in swine raised under commercial conditions in Brazil. Vet J. 172:526–531.
  • Brewster VR, Maiti HC, Tucker AW, Nevel A. 2017. Associations between EP-like lesions and pleuritis and post trimming carcass weights of finishing pigs in England. Livest Sci. 201:1–4.
  • Cvjetković V, Sipos S, Szabó I, Sipos W. 2018. Clinical efficacy of two vaccination strategies against Mycoplasma hyopneumoniae in a pig herd suffering from respiratory disease. Porc Health Manag. 4:19.
  • Del Carmen P, Carmona M, Lasierra M, Cárceles S, Espigares D. 2018. Assessment of the current situation of the porcine enzootic pneumonia and porcine pleuropneumonia in Spain using slaughterhouse lung evaluation. In: Proceedings of the 10th European Symposium of Porcine Health Management; May 9–11; Barcelona, Spain; pp. 190.
  • Del Pozo Sacristán R, Sierens A, Marchioro SB, Vangroenweghe F, Jourquin J, Labarque G, Haesebrouck F, Maes D. 2014. Efficacy of early Mycoplasma hyopneumoniae vaccination against mixed respiratory disease in older fattening pigs. Vet Rec. 174:197.
  • Dohoo I, Martin W, Strynh H. 2003. Veterinary epidemiologic research. Charlottetown (PEI): University of Prince Edward Island; p. 235–250.
  • Done S. 1991. Environmental factors affecting the severity of pneumonia in pigs. Vet Rec. 128:582–586.
  • Elbers ARW, Tielen MJM, Snijders JMA, Cromwijk WAJ, Hunneman WA. 1992. Epidemiological studies on lesions in finishing pigs in the Netherlands. I. Prevalence, seasonality and interrelationship. Prev Vet Med. 14:217–231.
  • Fablet C, Marois C, Dorenlor V, Eono F, Eveno E, Jolly JP, Le Devendec L, Kobisch M, Madec F, Rose N. 2012. Bacterial pathogens associated with lung lesions in slaughter pigs from 125 herds. Res Vet Sci. 93:627–630.
  • Fitzgerald RM, O’Shea H, Manzanilla EG, Moriarty J, McGlynn H, Calderón Díaz JA. 2020. Associations between animal and herd management factors, serological response to three respiratory pathogens and pluck lesions in finisher pigs on a farrow-to-finish farm. Porc Health Manag. 6:34.
  • Fraile L, Alegre A, López-Jiménez R, Nofrarías M, Segalés J. 2010. Risk factors associated with pleuritis and cranio-ventral pulmonary consolidation in slaughter-aged pigs. Vet J. 184:326–333.
  • Fuentes M, Pijoan C. 1987. Pneumonia in pigs induced by intranasal challenge exposure with pseudorabies virus and Pasteurella multocida. Am J Vet Res. 48:1446–1448.
  • Garcia-Morante B, Segales J, Fraile L, Perez de Rozas A, Maiti H, Coll T, Sibila M. 2016. Assessment of Mycoplasma hyopneumoniae-induced pneumonia using different lung lesion scoring systems: a comparative review. J Comp Pathol. 154:125–134.
  • Gardner IA, Willeberg P, Mousing J. 2002. Empirical and theoretical evidence for herd size as a risk factor for swine diseases. Anim Health Res Rev. 3:43–55.
  • Henninger M, Labarque G, Fily B, Auvigne V. 2014. Quantification of the relation between lung lesions at slaughter and growth performance from birth to slaughter – proposal for a new synthetic indicator. Journ Rech Porc. 46:183–184.
  • Hillen S, Bergc S, Köhler K, Reinacher M, Willems H, Reiner G. 2014. Occurrence and severity of lung lesions in slaughter pigs vaccinated against Mycoplasma hyopneumoniae with different strategies. Prev Vet Med. 113:580–588.
  • Jager KJ, Zoccali C, MacLeod A, Dekker FW. 2008. Confounding: what it is and how to deal with it. Kidney Int. 73:256–260.
  • Jensen CS, Ersbøll AK, Nielsen JP. 2002. A meta-analysis comparing the effect of vaccines against Mycoplasma hyopneumoniae on daily weight gain in pigs. Prev Vet Med. 54:265–278.
  • Kahlert J, Gribsholt SB, Gammelager H, Dekkers OM, Luta G. 2017. Control of confounding in the analysis phase – an overview for clinicians. Clin Epidemiol. 9:195–204.
  • Kim D, Kim CH, Han K, Seo HW, Oh Y, Park C, Kang I, Chae C. 2011. Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2. Vaccine. 29:3206–3212.
  • Krejci R, Mazerolles P, Mortier M. 2018. Lung scoring survey in European countries in 2017. In: Proceedings of the 10th European Symposium of Porcine Health Management; May 9–11; Barcelona, Spain; pp. 288.
  • Leneveu P, Robert N, Keïta A, Pagot E, Pommier P, Tessier P. 2005. Lung lesions in pigs at slaughter: a 2-year epidemiological study in France. Int J Appl Res Vet Med. 3:259–265.
  • Li R, Hu Y, Ge M, Zhao D, Yang T, Qing R, Yu X. 2019. Analysis of correlation between the detection rate of Mycoplasma hyopneumoniae in slaughter pigs and season, climate change, and presence of lung lesions. Med Weter. 75:175–178.
  • Madec F, Kobisch M. 1982. Bilan lésionnel des poumons de porcs charcutiers à l‘abattoir. Journ Rech Porc Fr. 14:405–412.
  • Maes D. 2010. Mycoplasma hyopneumoniae in pigs: update on epidemiology and control. In: D’Allaire S, Friendship R, editors. Proceedings of the 21st International Pig Veterinary Society Congress; Jul 18–21; Vancouver, Canada; p. 30–35.
  • Maes D, Deluyker H, Verdonck M, Castryck F, Miry C, Lein A, Vrijens B, de Kruif A. 1998. Effect of vaccination against Mycoplasma hyopneumoniae in pig herds with a continuous production system. J Vet Med. 45:495–505.
  • Maes D, Deluyker H, Verdonck M, Castryck F, Miry C, Vrijens B, Verbeke W, Viaene J, de Kruif A. 1999. Effect of vaccination against Mycoplasma hyopneumoniae in pig herds with an all-in/all-out production system. Vaccine. 17:1024–1034.
  • Maes D, Segales J, Meyns T, Sibila M, Pieters M, Haesebrouck F. 2008. Control of Mycoplasma hyopneumoniae infections in pigs. Vet Microbiol. 126:297–309.
  • Maes D, Verdonck M, Deluyker H, de Kruif A. 1996. Enzootic pneumonia in pigs. Vet Q. 18:104–109.
  • Marois C, Cariolet R, Morvan H, Kobisch M. 2008. Transmission of pathogenic respiratory bacteria to specific pathogen free pigs at slaughter. Vet Microbiol. 129:325–332.
  • Merialdi G, Dottori M, Bonilauri P, Luppi A, Gozio S, Pozzi P, Spaggiari B, Martelli P. 2012. Survey of pleuritis and pulmonary lesions in pigs at abattoir with a focus on the extent of the condition and herd risk factors. Vet J. 193:234–239.
  • Meyns T, Dewulf J, de Kruif A, Calus D, Haesebrouck F, Maes D. 2006. Comparison of transmission of Mycoplasma hyopneumoniae in vaccinated and non-vaccinated populations. Vaccine. 24:7081–7086.
  • Meyns T, Van Steelant J, Rolly E, Dewulf J, Haesebrouck F, Maes D. 2011. A cross sectional study of risk factors associated with pulmonary lesions in pigs at slaughter. Vet J. 187:388–392.
  • Moorkamp L, Nathues H, Spergser J, Tegeler R, Beilage EG. 2008. Detection of respiratory pathogens in porcine lung tissue and lavage fluid. Vet J. 175:273–275.
  • Ostanello F, Dottori M, Gusmara C, Leotti G, Sala V. 2007. Pneumonia disease assessment using a slaughterhouse lung-scoring method. J Vet Med. 5:70–75.
  • Pallarés FJ, Espigares D, Cano LD, Del Carmen P, Ramis G. 2018. Vaccination against Mycoplasma hyopneumoniae with Hyogen®: prevalence and severity of lung lesions. In: Proceedings of the 10th European Symposium of Porcine Health Management; May 9–11; Barcelona, Spain; pp. 231.
  • Pieters MG, Maes D. 2019. Mycoplasmosis. In: Zimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, Zhang J, editors. Diseases of swine. 11th ed. Hoboken (NJ): Wiley-Blackwell; p. 863–883.
  • Pourhoseingholi MA, Baghestani AR, Vahedi M. 2012. How to control confounding effects by statistical analysis. Gastroenterol Hepatol Bed Bench. 5:79–83.
  • Pujols J, Segalés J, Polo J, Rodríguez C, Campbell J, Crenshaw J. 2016. Influence of spray dried porcine plasma in starter diets associated with a conventional vaccination program on wean to finish performance. Porc Health Manag. 2:4.
  • Rabe-Hesketh S, Skrondal A. 2008. Multilevel and longitudinal modeling using stata. 2nd ed. College Station (TX): Stata Press; p. 317–322.
  • Rabe-Hesketh S, Skrondal A, Pickles A. 2005. Maximum likelihood estimation of limited and discrete dependent variable models with nested random effects. J Econom. 128:301–323.
  • Rodríguez F, Batista M, Hernández J, Afonso AM, Poveda JB. 2016. Relationship between expression of interleukin-5 and interleukin-13 by epithelial cells and bronchiolar changes in pigs infected with Mycoplasma hyopneumoniae. J Comp Pathol. 154:165–168.
  • Rodrigues da Costa M, Fitzgerald RM, Manzanilla ED, O’Shea H, Moriarty J, McElroy MC, Leonard FC. 2020. A cross-sectional survey on respiratory disease in a cohort of Irish pig farms. Ir Vet J. 73:24.
  • Sibila M, Nofrarías M, López-Soria S, Segalés J, Valero O, Espinalm A, Calsamiglia Μ. 2007. Chronological study of Mycoplasma hyopneumoniae infection seroconversion and associated lung lesions in vaccinated and non-vaccinated pigs. Vet Microbiol. 122:97–107.
  • Sibila M, Pieters M, Molitor T, Maes D, Haesebrouck F, Segalés J. 2009. Current perspectives on the diagnosis and epidemiology of Mycoplasma hyopneumoniae infection. Vet J. 181:221–231.
  • Thacker EL, Thacker BJ, Boettcher TB, Jayappa H. 1998. Comparison of antibody production, lymphocyte stimulation, and protection induced by four commercial Mycoplasma hyopneumoniae bacterins. J Swine Health Prod. 6:107–112.
  • Tizard I.R. 2017. Vaccines and their production. In: Tizard I.R., editor. Veterinary immunology. 10th ed. St. Louis (MO): Elsevier/Saunders; p. 258–271.
  • Vanhara J, Jirasek T, Krejci R, Sperling D. 2018. Evaluation of the prevalence and severity of enzootic pneumonia and pleuropneumonia on Czech pig farms based on lung lesion scoring in the years of 2015–2017. In: Proceedings of the 10th European Symposium of Porcine Health Management; May 9–11; Barcelona, Spain; pp. 332.
  • Villarreal I, Meyns T, Dewulf J, Vranckx K, Calus D, Pasmans F, Haesebrouck F, Maes D. 2011. The effect of vaccination on the transmission of Mycoplasma hyopneumoniae in pigs under field conditions. Vet J. 188:48–52.
  • Wilson S, Van Brussel L, Saunders G, Taylor L, Zimmermman L, Heinritzi K, Ritzmann M, Banholzer E, Eddicks M. 2012. Vaccination of piglets at 1 week of age with an inactivated Mycoplasma hyopneumoniae vaccine reduces lung lesions and improves average daily gain in body weight. Vaccine. 30:7625–7629.
  • Yang S, Park SJ, Oh T, Cho H, Chae C. 2020. Efficacy comparison of commercial porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae monovalent and bivalent vaccines against a dual challenge. Can J Vet Res. 84:272–282.